The ‘Moderate’ Valve Leak That Hits Your Most Stable Heart Failure Patients Hardest

Key Takeaway

In a large-scale heart failure trial, moderate secondary mitral regurgitation was independently associated with an 11% increase in the risk of heart failure events or cardiovascular death. This adverse prognostic impact was paradoxically most pronounced in patients with milder underlying disease. Because moderate regurgitation did not independently predict all-cause mortality, these findings call for heightened clinical surveillance rather than a reflexive referral for transcatheter edge-to-edge repair.

The Leak in the Stable Patient

Consider a 64-year-old woman with NYHA class II functional capacity and a left ventricular ejection fraction of 35%. Optimized on guideline-directed medical therapy (GDMT), her NT-proBNP levels have finally begun to trend downward. Yet nestled within her echocardiogram report is a single line that many clinicians might breeze past: moderate functional mitral regurgitation. It is tempting to dismiss this finding as a mere bystander—a hemodynamic shadow cast by a dilated ventricle that will wax or wane alongside the underlying cardiomyopathy. For decades, clinicians have debated whether secondary mitral regurgitation (SMR) actively drives poor outcomes or simply mirrors the extent of myocardial damage^[2]. A rigorous new analysis indicates that this shadow carries substantial clinical weight. In heart failure with reduced ejection fraction…